This site is updated Hourly Every Day

Trending Featured Popular Today, Right Now

Colorado's Only Reliable Source for Daily News @ Marijuana, Psychedelics & more...

Post: Sam Altman’s Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA

Picture of Anschutz Medical Campus

Anschutz Medical Campus

AnschutzMedicalCampus.com is an independent website not associated or affiliated with CU Anschutz Medical Campus, CU, or Fitzsimons innovation campus.

Recent Posts

Anschutz Medical Campus

Sam Altman's Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA
Facebook
X
LinkedIn
WhatsApp
Telegram
Threads
Email

Zinger Key Points Altman recently opened up about his psychedelic experiences, which helped him overcome anxiety.

He is now investing in psychedelic therapies like MDMA to treat mental health conditions through his start-up, Journey Colab

Sam Altman , co-founder of OpenAI and the visionary behind ChatGPT , recently opened up about his transformative experiences with psychedelics in his appearance on the podcast Life in Seven Songs . The tech executive shared personal anecdotes about how psychedelic experiences profoundly impacted his mental health, helping him overcome anxiety and find happiness.

Altman told to host Sophie Bearman that he once considered himself a “very anxious, unhappy person,” but psychedelic experiences—particularly a retreat in Mexico—changed his life significantly. “Doing psychedelics was one of the most transformative experiences of my life,” he said, noting that the experience helped him become a “calm person” and allowed him to focus more effectively on his work.

While Altman did not specify which psychedelics he used, he did mention that the Mexico retreat was particularly significant. “If you had told me that, like, one weekend-long retreat in Mexico was going to significantly change that, I would have said absolutely not. And it really did,” Altman remarked, highlighting the unexpected impact the experience had on his mental state. Altman’s Vision For Safe And Effective Psychedelic Therapy: Journey Colab

Altman is now setting his sights on transforming mental health care with psychedelic drugs. According to Business Insider, as chairman of the start-up Journey Colab , he is investing in the potential of psychedelics such as MDMA and psilocybin to treat mental health conditions like depression, PTSD and drug addiction.

Journey Colab, led by CEO Jeeshan Chowdhury , aims to guide these powerful substances through the final stages of clinical trials and develop a safe, effective model for administering them. Their approach is to work with luxury rehab centers like All Points North to ensure that psychedelic treatments are offered in controlled, high-support environments.

Altman says his interest in psychedelics stems from their unrealized potential. Reflecting on early MDMA studies, he said, “I remember looking at it thinking, like, ‘That can’t be real, […]

Leave a Reply

Your email address will not be published. Required fields are marked *

You Might Be Interested...